People Briefs: Covidien CFO To Retire; Appointments At ConvaTec, Metamark, NeuroSigma, Uroplasty

Covidien Chief Financial Officer Charles Dockendorff announces retirement. ConvaTec, Metamark, NeuroSigma and Uroplasty appoint executives. More people briefs.

Charles J. Dockendorff, executive VP and chief financial officer of diversified medical device firm Covidien PLC, plans to retire at the end of this year, the company announced Jan. 27. Dockendorff joined Covidien’s predecessor company, Kendall Healthcare Products Co., in 1989, rising from controller to CFO of Kendall parent firm Tyco Healthcare in 1995. Covidien will consider both internal and external candidates to replace the longtime executive. “We anticipate a seamless transition,” José E. Almeida, Covidien chairman, president and CEO, said Jan. 27.

The privately held medtech manufacturer ConvaTec Inc. said Jan. 27 that John Cannon has been named chief financial officer, having...

More from Archive

More from Medtech Insight